Home
Scholarly Works
Homocysteine Lowering Therapy And Stroke Risk,...
Conference

Homocysteine Lowering Therapy And Stroke Risk, Severity And Disability: Results From The HOPE-2 Trial

Authors

Saposnilk G; Ray J; Sheridan P; McQueen M; Lonn E

Volume

40

Pagination

pp. E131-E131

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

April 1, 2009

Name of conference

American-Association-International-Stroke Conference 2009

Conference place

San Diego, CA

Conference start date

February 17, 2009

Conference end date

February 20, 2009

Conference proceedings

STROKE

Issue

4

ISSN

0039-2499

Contact the Experts team